Australia markets closed

Zymeworks Inc. (ZYME)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
5.92+0.11 (+1.89%)
At close: 04:00PM EDT
5.85 -0.07 (-1.18%)
Pre-market: 09:01AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 346.05M
Enterprise value 77.36M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)11.71
Price/book (mrq)1.23
Enterprise value/revenue 2.77
Enterprise value/EBITDA -0.33

Trading information

Stock price history

Beta (5Y monthly) 1.06
52-week change 3-80.17%
S&P500 52-week change 3-5.29%
52-week high 339.41
52-week low 34.56
50-day moving average 36.17
200-day moving average 316.31

Share statistics

Avg vol (3-month) 31.81M
Avg vol (10-day) 31.53M
Shares outstanding 557.77M
Implied shares outstanding 6N/A
Float 843.15M
% held by insiders 16.13%
% held by institutions 189.06%
Shares short (12 May 2022) 48.02M
Short ratio (12 May 2022) 42.47
Short % of float (12 May 2022) 413.88%
Short % of shares outstanding (12 May 2022) 413.88%
Shares short (prior month 13 Apr 2022) 47.26M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin 0.00%
Operating margin (ttm)-872.86%

Management effectiveness

Return on assets (ttm)-33.15%
Return on equity (ttm)-72.74%

Income statement

Revenue (ttm)27.95M
Revenue per share (ttm)0.52
Quarterly revenue growth (yoy)197.50%
Gross profit (ttm)-172.86M
EBITDA -238.89M
Net income avi to common (ttm)-239.88M
Diluted EPS (ttm)-4.97
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)300.53M
Total cash per share (mrq)5.2
Total debt (mrq)31.84M
Total debt/equity (mrq)11.27
Current ratio (mrq)4.05
Book value per share (mrq)4.89

Cash flow statement

Operating cash flow (ttm)-207.06M
Levered free cash flow (ttm)-120.02M